Related by context. All words. (Click for frequent words.) 73 MAGE A3 ASCI 72 Initiates Phase II 72 forodesine 72 non nucleoside inhibitor 71 oral prodrug 71 INCB# [001] 71 Completes Patient Enrollment 71 LymphoStat B TM 70 GVAX ® 70 Initiates Clinical 70 treatment naïve genotype 70 Reports Preclinical Data 70 AEG# 70 HGS ETR1 mapatumumab 70 R#/MEM # 70 treatment naive genotype 70 cMET 70 Initiate Phase 70 Initiates Enrollment 70 Vicriviroc 70 THR beta agonist 70 Phase III Pivotal 70 INSPIRE Trial Phase III 70 ALN VSP Phase 70 Thiovir 69 LymphoStat B belimumab 69 HGS ETR2 69 HQK 69 Meets Primary Endpoint 69 Presents Preclinical 69 PSMA ADC 69 Civacir 69 FOLOTYN ® 69 HCD# [002] 69 Xcytrin R 69 Phase 2b Clinical Trial 69 budesonide foam 69 Initiates Phase III 69 CYT# potent vascular disrupting 69 Achieves Primary Endpoint 69 nucleotide analog 68 Inhalation Solution 68 Begins Dosing 68 Rigel R# 68 Omacetaxine 68 pharmacogenomic translational research 68 multicenter Phase II 68 Personalized Immunotherapy 68 Phase 2a clinical trials 68 Initiates Clinical Trial 68 novel VDA molecule 68 anticoagulant reversing agent 68 Initiate Clinical Trial 68 nucleoside analog 68 sorafenib tablets 68 TransVax ™ 68 systemic RNAi therapeutic 68 orally administered inhibitor 68 initiated Phase Ib 68 GRNVAC1 68 GERD migraine headaches 68 Aflibercept 68 markets Testim ® 68 CCR5 receptor antagonist 68 Pafuramidine 68 Successfully Completes Phase 68 Inc. www.micromet inc.com 68 novel therapeutic antibodies 68 TBC# 68 thiazolides 68 Protexia ® 68 hyaluronidase enzyme 68 telaprevir VX 68 evaluating tivozanib 68 acetonide FA 67 DEB# 67 Panzem R 67 Gamunex C 67 adecatumumab MT# 67 therapeutic monoclonal antibody 67 alvespimycin 67 intranasal formulation 67 midstage clinical 67 Initiates Phase 2b 67 PD LID 67 IMiDs ® 67 HDL Selective Delipidation 67 albiglutide 67 mertansine 67 Cethromycin 67 SNT-MC#/idebenone 67 Factor VIIa 67 telomerase therapeutic 67 systemically administered 67 CCX# 67 Presents Preclinical Data 67 torezolid phosphate 67 lead Aganocide compound 67 DermaVir Patch 67 TransVax tm 67 IMA# 67 Vitrasert R 67 Presents Positive 67 TOCOSOL Camptothecin 67 Trofex 67 phase III isavuconazole 67 Sudhir Agrawal D.Phil 67 human IgG1 monoclonal 67 BARACLUDE R 67 phase IIb study 67 trastuzumab Herceptin R 67 Albuferon albinterferon alfa 2b 67 AAG geldanamycin analog 67 Crofelemer budesonide foam 67 kidney urologic 67 Forodesine HCl 67 Phase #b/#a clinical 67 factor TNF receptor 67 lintuzumab SGN 67 Glufosfamide 67 ospemifene 67 MGd 67 Talabostat 67 Virulizin ® 67 CEQ# 67 HuMax TAC 67 Solazed 67 vapreotide acetate 67 huC# DM4 67 Archexin 67 Oral Calcitonin 67 Vaccine Adjuvant 67 Receives Fast Track 67 metaglidasen 67 JVRS 67 Maribavir 67 interferon gamma 1b 67 methylnaltrexone bromide 67 omega interferon 67 Antibody Drug Conjugate 67 MyVax R 67 refractory chronic lymphocytic 67 PEG SN# 66 stated Michelle Berrey 66 successfully commercialize Iluvien 66 Aclidinium 66 HCV RNA polymerase 66 Nanobody R 66 TransVax TM 66 PHX# 66 OvaRex ® MAb 66 relapsed MM 66 Submits IND 66 Submits Response 66 dose intramuscular 66 Aurexis 66 RiVax 66 Panzem R NCD 66 Hsp# Inhibitor 66 ChronVac C 66 virus HCV protease inhibitor 66 oral picoplatin 66 Zemplar Capsules 66 Bayer HealthCare Onyx Pharmaceuticals 66 Phase Ib IIa 66 HuCAL antibodies 66 VEGFR2 inhibitor 66 Reverset 66 ALN PCS 66 Submits Biologics License Application 66 trastuzumab DM1 T DM1 66 Neugene 66 Alfacell proprietary ribonuclease 66 PI3K/Akt pathway inhibitor 66 Phase III ADT 66 radezolid 66 MyVax ® 66 MEK inhibitor 66 non nucleoside HCV 66 Sapacitabine 66 Protexia R 66 OvaRex R 66 Elagolix 66 KNS # 66 ENMD # 66 JAK2 inhibitor 66 Tezampanel 66 Pivotal Phase III 66 YONDELIS 66 NS5b 66 XL# anticancer compounds 66 reduce serum phosphate 66 oral ridaforolimus 66 DDP# 66 phase Ib 66 Therapeutic Competitors Companies 66 orally inhaled migraine 66 HIV coinfected 66 HGS# 66 Naive Patients 66 KRN# 66 Phase 2b Trial 66 docetaxel Taxotere R 66 PLK1 SNALP 66 Phase IIb clinical trials 66 ZADAXIN ® 66 refractory CLL 66 IMiDs 66 Granted Orphan Drug 66 Daclizumab 66 Pimavanserin 66 TRIOLEX HE# APOPTONE HE# 66 MKC# MT 66 AKT inhibitor 66 RTP #i 66 Lenocta 66 CD# CEA 66 MAXY alpha 66 Receives Orphan Drug 66 SinuNase ™ 66 Belimumab 66 Potelligent Technology 66 GED aPC 66 Viramidine 66 Receive Milestone Payment 66 oral ghrelin agonist 66 small molecule Hedgehog 66 Multimeric 66 GLP toxicology studies 66 targeted radiotherapeutic 66 PEG Interferon lambda 66 small molecule thrombopoietin 66 TELINTRA R 66 RECOTHROM R 66 TKM PLK1 66 agonistic human 66 huN# DM1 66 ZOLINZA 66 JAK inhibitor 66 urocortin 2 66 fosbretabulin 66 humanized therapeutic 65 recombinant PSMA vaccine 65 investigational oral hepatitis C 65 HGS ETR1 65 Pegloticase 65 MEK Inhibitor 65 IMPDH inhibitor 65 inhaled AAT 65 HCV NS5B polymerase 65 CR# vcMMAE 65 novel histone deacetylase 65 Phase IIb Clinical Trial 65 selective modulator 65 Elvitegravir 65 compound INCB# 65 Commences Phase 65 delivers fluocinolone acetonide FA 65 evaluating picoplatin 65 JAK2 Inhibitor 65 Bafetinib 65 PNP inhibitor 65 Phase IIA 65 MT#/MEDI-# 65 PDE# inhibitors 65 pralatrexate injection folate analogue 65 MKC# 65 reslizumab 65 JAK#/JAK# inhibitor CYT# 65 PRT# 65 Prodarsan R 65 R MSCRAMM 65 Proellex TM 65 Metastatic Melanoma 65 ThermoDox ® clinical 65 forodesine hydrochloride 65 Kosan dependence 65 oral Janus kinase 65 Poly ICLC 65 Pivotal Phase 65 Phase Ib study 65 recurrent metastatic ovarian cancer 65 PRTX 65 R sorafenib tablets 65 Degarelix 65 vidofludimus 65 recurrent glioma 65 leading oral taxane 65 UPLYSO 65 Aganocide 65 EOquin TM 65 Aganocide ® 65 davunetide intranasal AL 65 Saforis 65 please visit http:/www.sunesis.com 65 Syncria 65 selective androgen receptor modulator 65 including eniluracil ADH 65 toenail onychomycosis 65 PROVENGE ® 65 Testosterone MDTS ® 65 markets HP Acthar 65 PORxin TM platforms 65 BRIM3 65 apricitabine ATC 65 Protease Inhibitor 65 NEUGENE 65 stage antibody MT# 65 riociguat 65 RELOVAIR ™ 65 azilsartan medoxomil 65 Aeolus Pharmaceuticals Announces 65 Receives Orphan Drug Designation 65 therapeutic monoclonal antibodies 65 PDX pralatrexate 65 SAR# [002] 65 Tasimelteon 65 mGluR5 NAM 65 Methylnaltrexone 65 PROSTVAC VF 65 VitiGam 65 TLK# 65 Bezielle 65 HuMax EGFr 65 hyperphenylalaninemia HPA due 65 Teplizumab 65 ALN TTR 65 immunotherapeutic vaccine 65 synthetic retinoid 65 Completes Enrollment 65 Deforolimus 65 AMD# [002] 65 candidate XP# 65 docetaxel Taxotere ® 65 class mGluR5 inhibitor 65 Veronate R 65 R#/MEM 65 Exherin TM 65 thetreatment 65 Muraglitazar 65 HCV protease inhibitors 65 XL# XL# XL# XL# 65 Somatuline Depot 65 recurrent glioblastoma multiforme 65 Genasense oblimersen sodium Injection 65 thymalfasin 65 Empatic ™ 65 diarrhea predominant irritable 65 VGV 1 65 opioid induced bowel dysfunction 65 Pathway Inhibitor 65 Alzhemed TM 65 molecular chaperone regulation 65 Submits NDA 65 GSK# [002] 65 TNFerade TM 65 Parkinson disease levodopa induced 65 Fx #A 65 Behcet uveitis 65 Valopicitabine 65 Aviptadil 65 busulfan 65 oncolytic virus therapies 65 Naglazyme R 65 Seliciclib 65 Romidepsin 65 Vitaxin 65 NP2 Enkephalin 65 soluble tumor necrosis 65 Maxy G# 65 Presents Positive Preclinical 65 multicenter Phase III 65 Cloretazine ® 65 Cancidas 65 OMNARIS HFA 65 NPC 1C 65 ALN VSP 65 Telik logo TELINTRA 65 pDNA vaccine 65 MOVIPREP R 65 TRO# 65 Oracea TM 65 neuronal nicotinic receptor NNR 65 Azedra TM 65 highly purified pasteurized 65 Nitazoxanide 65 solid tumors ZYBRESTAT 65 PrevOnco 65 Panzem NCD 65 Sustiva efavirenz 65 Darinaparsin 65 Cloretazine 65 Combination REOLYSIN R 65 PANVAC VF 65 IAP inhibitor 65 ganetespib 65 INS# [001] 65 fusion enhancers 64 eniluracil 64 OHR/AVR# 64 Spiegelmer ® 64 XP# XP# 64 Evoltra ® 64 refractory gout 64 lumiliximab 64 Matrix Phase 2b 64 PrevOnco ™ 64 Files IND 64 TASKi3 64 OMP #M# 64 rALLy clinical trial 64 TRAIL receptor antibodies 64 polymerase inhibitor 64 incyclinide 64 TNFerade ™ 64 inhibitor RG# 64 developing ACAPODENE 64 Completes Dosing 64 Phase 1a clinical 64 Entereg R 64 Shigamabs ® 64 Vaxfectin 64 Golimumab 64 GRN# 64 Lixivaptan 64 Clolar ® 64 PKC# 64 generation URAT1 inhibitor 64 Myocet 64 gastro intestinal inflammation 64 PRN FDA Approves 64 lucinactant 64 Anidulafungin 64 ADP receptor antagonist 64 OncoVEX GM CSF 64 CCR5 antagonist 64 Ostarine ™ 64 MNTX 64 antibody MAb 64 drug pipeline TAFA# 64 pharmacokinetic PK study 64 Albuferon TM 64 Soliris eculizumab 64 phase IIb clinical 64 ZALBIN 64 Albugon 64 Ophena TM 64 R roscovitine 64 cytokine refractory 64 MSCRAMM ® 64 Vitrasert ® 64 Phase Ib II 64 OMP #R# 64 Zenvia ™ 64 tramiprosate Alzhemed TM 64 KAI Pharmaceuticals 64 IAP inhibitors 64 Initiate Phase III 64 preclinical efficacy 64 subcutaneous PRO 64 targeting CD# 64 Bioral Amphotericin B 64 Testosterone MDTS R 64 acyclovir Lauriad R 64 Hepatitis C Virus HCV 64 GeoVax HIV AIDS 64 personalized immunotherapy 64 BRIM2 64 CCR9 antagonist 64 Etubics 64 liposomal formulation 64 protein tyrosine phosphatase 1B 64 faropenem medoxomil 64 Vaxfectin ® 64 Altastaph 64 elotuzumab 64 proprietary intranasal insulin 64 humanised monoclonal antibody 64 DermaVir 64 5 fluorouracil leucovorin 64 Refractory Angina 64 Gilead Viread 64 THALOMID 64 Annamycin 64 pharmacodynamic properties 64 Safinamide 64 opioid bowel dysfunction 64 TransVax 64 receptor inhibiting monoclonal 64 L BLP# 64 platform HDL Mimetic 64 ChronVac C R 64 TYZEKA 64 hepatitis B immune globulin 64 Elotuzumab 64 Tesmilifene 64 trodusquemine 64 galiximab 64 Genasense ® oblimersen 64 LymphoStat B 64 PEGylated interferon 64 G#DT 64 GATTEX ™ 64 Ecallantide 64 MT# MEDI 64 Kahalalide F 64 Phase IIb III 64 Phase IIIb clinical 64 investigational humanized monoclonal antibody 64 investigational monoclonal antibody 64 NeuroSTAT ® 64 discontinued Viread 64 daptomycin 64 Randomized Phase 64 Phase lll 64 DIFICID ™ 64 Fovea Pharmaceuticals subsidiary 64 Alinia 64 generation Hsp# inhibitor 64 Georges Gemayel 64 #I TM# 64 AVP #D# 64 GATTEX ® 64 neuropathic pain spasticity 64 HCV polymerase 64 developing Zerenex ferric 64 Arimoclomol 64 Traficet EN 64 virus AAV 64 Iluvien ® 64 CRMD# 64 Parathyroid Hormone 64 NS#/#A protease 64 investigational integrase inhibitor 64 SinuNase TM 64 ALN HPN 64 Telbivudine 64 NS5B polymerase 64 lexidronam injection 64 LibiGel ® 64 IL# PE#QQR 64 MVA BN R 64 blinded randomized placebo controlled 64 Liprotamase 64 hepatitis C polymerase inhibitor 64 Zalypsis 64 Tarvacin TM 64 bazedoxifene conjugated estrogens 64 TNF alpha selectively neutralizing 64 Immunotherapeutic 64 TRANSDUR ™ 64 velafermin 64 Amigal TM 64 maximally tolerated dose 64 Phase #b/#a 64 GAMMAGARD 64 ApoB SNALP 64 pathophysiological effects 64 next generation URAT1 64 candidate REP# 64 Genz # 64 ZFP Therapeutics 64 Insegia 64 humanized interleukin 6 64 preclinically 64 COLAZAL R 64 candidate TNFerade biologic 64 cytomegalovirus immune globulin 64 rxRNA 64 Atripla combines 64 product platforms AZX# 64 essential thrombocythemia ET 64 EXPLORE Xa 64 Receives Approvable Letter 64 Ceflatonin ® 64 Proleukin 64 DURIN TM 64 Prestara 64 Ceflatonin R 64 ELADUR ™ 64 Zenvia TM 64 Ozarelix 64 Present Preclinical Data 64 peripherally acting 64 IMC #B 64 Phase IIb Trial 64 delivery polymer matrix 64 CTAP# Capsules 64 CIMZIA TM certolizumab pegol 64 Androxal TM 64 oral methylnaltrexone 64 PSN# [002] 64 generation NNRTI 64 Prochymal TM 64 MEND CABG II 64 diabetic neuropathic pain 64 monoclonal antibody conjugated 64 personalized dendritic cell 64 VivaGel TM 64 RSD# oral 64 EVIZON TM 64 cannabinor 64 naive HCV genotype 64 CMV vaccine 64 CYP#A# CYP#D# 64 selective kinase inhibitor 64 midstage trials 64 ALTROPANE R 64 TRACON Pharmaceuticals 64 RenaZorb TM 64 relapsing remitting MS RRMS 64 GMX# 64 Ceflatonin 64 Aryplase 63 HCV NS3 protease 63 eTag assays 63 Lubiprostone 63 investigational hepatitis B 63 NEUMUNE 63 2 methoxyestradiol 63 H#N# VLP vaccine 63 OncoVex 63 approved incretin mimetic 63 RANK Ligand inhibitor 63 targeting miR 63 Stimuvax R 63 oral salmon calcitonin 63 personalized dendritic 63 Neulasta R 63 please visit http:/www.vandapharma.com 63 ongoing Phase 1b 63 Solazed TM 63 Alferon LDO 63 Mg Usa 63 OncoVEX 63 rPA anthrax vaccine 63 REG1 Anticoagulation System 63 TASKi2 63 Epothilones 63 evaluating bafetinib 63 Syncria R 63 dimebon latrepirdine 63 Multiple Ascending Dose 63 Initiates Dosing 63 TKB# 63 Besivance 63 Advanced Melanoma 63 tezampanel 63 CEL SCI Phase III 63 By JENNIFER LEARN 63 Aurora kinase inhibitor 63 Provectus Pharmaceuticals specializes 63 Trastuzumab DM1 63 E1 INT TM 63 Kinase Inhibitor 63 selective orally bioavailable 63 antisense drug 63 oral dihydropyrimidine dehydrogenase DPD 63 Azedra 63 FOLFOX6 chemotherapy regimen 63 Allovectin 7 R 63 myelodysplastic myeloproliferative diseases 63 antisense inhibitors 63 prasterone 63 evaluating mipomersen 63 Initiates Phase 63 glucokinase activator 63 Prodarsan ® 63 receptor tyrosine kinase inhibitor 63 pain palliation 63 Curaxin CBLC# 63 immunomodulatory properties 63 pegylated recombinant 63 HuLuc# 63 GW# [003] 63 GALNS 63 Therapeutic Vaccine 63 SPL# Gel vaginal microbicide 63 Phase III Clinical Trial 63 initiate Phase 1b 63 Phase #/#a 63 visit www.targanta.com 63 Oral NKTR 63 MET amplification 63 pharmacodynamic PD 63 Aliskiren 63 Zoraxel 63 anti botulism antibody 63 bardoxolone 63 XYOTAX TM 63 introduced NEUGENE 63 Earns Milestone Payment 63 BIM #A# 63 aerosolized AAT 63 Anturol TM 63 oral FTY# 63 Vivecon 63 REGN# 63 MET inhibitor 63 KSP inhibitor 63 PEG PAL 63 First Patient Enrolled 63 HCV polymerase inhibitors 63 novel emulsion formulation 63 TPI ASM8 63 oral renin inhibitor 63 beta 1a 63 Receives Milestone Payment 63 RECOTHROM ® 63 PhG alpha 1 63 Genasense ® 63 Tibotec BVBA 63 neratinib 63 oral nucleoside analogue 63 histone deacetylase inhibitor 63 Exelixis compounds 63 subsidiaries visit http:/www.apricusbio.com 63 5 HT3 antagonist 63 IV acetaminophen 63 Hedgehog Pathway Inhibitor 63 PDE4 inhibitor 63 SNT MC# 63 anti CD3 antibody 63 Phenoptin 63 oral PTH 63 ORENCIA R 63 Entry Inhibitor 63 DCVax R 63 TOLAMBA 63 peptidic compound 63 novel peptide 63 Tyrima 63 CORT # 63 LAB CGRP 63 ONCONASE R 63 WX UK1 63 intranasal delivery 63 GTC recombinant human 63 Sym# 63 TACI Ig 63 zanolimumab 63 Peginterferon alfa 2b 63 apricitabine 63 ORMD 63 non peptidic protease 63 Second Pivotal Phase 63 RhuDex ® 63 administered intranasally 63 MCSP respectively 63 oral antiviral 63 Silodosin 63 VitiGam TM 63 Aplidin R 63 novel immunotherapies 63 velafermin belinostat 63 anthrax monoclonal antibody 63 Adjuvanted 63 EP #R 63 initiated Phase 1b 63 Tyrosine Kinase Inhibitor 63 metreleptin 63 LEVADEX ™ 63 Pyridorin TM 63 please visit http:/www.atherogenics.com 63 LUX Lung 63 LibiGel ® testosterone gel 63 Inc. Nasdaq IMGN 63 Symadex 63 Kuvan R 63 Nasdaq HALO 63 website http:/www.celsion.com 63 Blinatumomab 63 hypoxia activated prodrug 63 Demonstrates Positive 63 HDL Mimetic Peptide 63 potent nucleoside analogue 63 orally bioavailable 63 EmbraceAC 63 Copegus ribavirin 63 novel nucleoside analog 63 dependent kinase inhibitor 63 Alvine Pharmaceuticals 63 Fodosine 63 R lenalidomide 63 Tarvacin Anti Cancer 63 KRYSTEXXA TM pegloticase 63 Zybrestat 63 Nasdaq SGEN 63 depsipeptide 63 sodium glucose cotransporter 63 includes TOLAMBA TM 63 P#X# antagonist 63 plus Copegus R 63 non nucleoside 63 Egrifta 63 XmAb 63 hormone agonist 63 nalbuphine ER 63 INT# [002] 63 adenoviral vectors 63 therapeutically inactive prodrug 63 Saquinavir 63 VIVITROL ® 63 investigational protease inhibitor 63 retinal vein occlusion induced 63 Aztreonam lysine 63 Vertex hepatitis C 63 IMVAMUNE TM 63 recombinant biopharmaceutical 63 Phase Ib clinical trials 63 dasatinib Sprycel 63 IMiDs R 63 Antitumor Activity 63 topical gel formulation 63 SPRYCEL ® 63 mGluR2 NAM 63 EOquin TM phase 63 selective S#P# receptor agonist 63 Valortim TM 63 PROSTASCINT R 63 MKC# MKC# PP 63 p# biomarker 63 SNS# T 63 ZFP Therapeutic 63 pegylated interferon alfa 2a 63 pan histone deacetylase 63 Investigational Oral 63 severe gastroparesis 63 Cethrin R 63 APTIVUS 63 adrenergic regulation 63 pan HDAC inhibitor 63 LB# [003] 63 NeuVax 63 OXi# 63 Sphingomab TM 63 EDEMA3 63 Teriflunomide 63 Aurora Kinase 63 Ramoplanin 63 HCV protease inhibitor 63 HTS assay 63 Selective Electrochemical Tumor Ablation 63 radiation sensitizer 63 Granulocyte Colony Stimulating Factor 63 XOMA 3AB 63 HEPLISAV TM 63 JAK inhibitors 63 mda 7 63 ATRA IV 63 Temsirolimus 63 ZFN modified 63 nucleoside reverse transcriptase inhibitor 63 Kuvan sapropterin dihydrochloride 63 ® lenalidomide 63 ddRNAi 63 oral deforolimus 63 methylnaltrexone 63 tanespimycin 63 Zadaxin 63 recombinant subunit vaccine 63 candidate deforolimus 63 drug conjugate 63 CINQUIL 63 dyskinesia PD LID 63 Trial Evaluating 63 signal detection CTSD 63 Dose Escalation 63 Dapagliflozin 63 First Patient Dosed 63 HuCAL GOLD R 63 Iloperidone 63 valopicitabine NM# 63 programs visit http:/www.bionovo.com 63 arsenic trioxide injection 63 CRD5 63 Bicifadine 63 siRNA therapeutics 63 Clinical Trial Results 63 BEMA Granisetron 63 aplindore 63 Mipomersen 63 vivo toxicology 63 compound KOS 63 oral Azacitidine 63 TRANSDUR ® 63 either acutely decompensated 63 vaginal candidiasis 63 gp# protein [002] 63 small molecule agonists 63 Xcellerated T Cells 63 mg kg BID 63 GLYX 63 alfa 2a 63 r hGH 63 VivaGel ™ 63 Viread tenofovir disoproxil fumarate 63 oral Hsp# inhibitor 63 Epidermal Growth Factor Receptor 63 registrational trial 63 Nasdaq PGNX today 63 myelofibrosis polycythemia vera 63 Survivin antagonist 63 ARIKACE ™ 63 pharmacodynamic markers 63 ritonavir boosted danoprevir 63 mapatumumab 63 Shigamabs R 63 Fast Track Status 63 NV1FGF 63 AERx ® 63 Phase 2a Trial 63 favorable pharmacokinetic profile 63 XL# XL# 62 Phase 2a trial 62 Tß4 62 Universal Flu Vaccine 62 Kamada AAT 62 Darapladib 62 Epratuzumab 62 fidaxomicin Phase 62 inhalation powder 62 RAPTIVA 62 Apaziquone 62 potently inhibit 62 CB2 selective receptor agonist 62 faropenem 62 dasatinib Sprycel ® 62 virus HCV 62 novel synthetic PEGylated 62 hemagglutination inhibition 62 isoform selective 62 highly selective inhibitor 62 SCIB1 62 RNAi Therapeutic 62 AV HALT 62 Merck Serono Nycomed 62 pradefovir 62 oral talactoferrin 62 visit www.sciclone.com 62 cutaneous T 62 Triapine R 62 RhuDex 62 thrombin component 62 Novel Oral 62 SAR# [004] 62 plus prednisone prednisolone 62 Oral Fingolimod 62 pharmacodynamic profile 62 Anti Tumor 62 CA9 SCAN 62 Phase 1b trial 62 Tectin TM 62 CRLX# 62 canakinumab 62 NU# direct 62 proprietary PEGylation 62 staphylococcal vaccine 62 DAS# Fludase ® 62 ARRY # 62 Epothilone D 62 ART# 62 thalidomide Thalomid 62 Listeria vaccine 62 CDAD Clostridium difficile 62 epigenetic therapies 62 M# rationally 62 Etravirine 62 hypereosinophilic syndrome 62 Plicera 62 JAK Inhibitor 62 Lenocta TM 62 MAGE A3 62 generation purine nucleoside 62 Trofex TM 62 CIP ISOTRETINOIN 62 tolerability pharmacokinetics 62 Phase III multicenter 62 EndoTAGTM 1 62 Thalomid ® 62 Phase Ib clinical 62 samalizumab 62 refractory cutaneous T 62 personalized cellular immunotherapy 62 rFactor XIII 62 nucleotide analogue 62 DXL# 62 microtubule inhibitor 62 Randomized Phase II 62 AdVac ® 62 BENLYSTA ® 62 orally inhaled 62 constipation OIC 62 Alferon N 62 taxane resistant 62 Xeloda ® 62 nicotinic alpha 7 62 oral dnaJP1 62 virosome